Marshall Goldsmith

FEBRUARY 8, 2018

Co-founder of Rose Park Advisors—Disruptive Innovation Fund. A leading thinker on strategy and breakthrough innovation. World leading researcher on the impact of leadership in organizations. Deepa Prahalad – Focused on design and emerging markets. Telisa Yancy – Chief Marketing Officer at American Family Insurance.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Strategy Driven

JUNE 22, 2018

The more interactions and positive experiences that your customers have with you, the more likely they are to convert from consumer into a brand advocate, and so the message of your brand will spread organically. By adapting your marketing strategy, you will be able to target new audiences for your products and services.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Harvard Business Review

FEBRUARY 16, 2017

Most businesses wouldn’t survive without driving demand for their products or services, either through marketing and advertising or through involving users so deeply in the design of the product that word of mouth spurs adoption. The same is true for social innovators. But even the most needed innovation does not sell itself.

Innovation 8

Innovation Rogers NGO Participative 8

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

JUNE 7, 2012

The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure. Pharmaceutical patent expirations are increasing the use of cheaper generic drugs.

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. The skepticism is warranted. But it does happen.

Innovation 10

Innovation P&L Short-term Company 10

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JUNE 7, 2012

The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure. Pharmaceutical patent expirations are increasing the use of cheaper generic drugs.

Disruptive Innovation 12

Disruptive Innovation Innovation Pharmaceuticals Class 12

Harvard Business Review

OCTOBER 6, 2016

In a Deloitte study of 7,000 organizations this year, 89% of executives rated “ strengthening the leadership pipeline ” an urgent issue. Organizations are continuously promoting people into management, and those new leaders struggle with the transition. It’s not that development itself isn’t important.

Leadership Pipeline 11

Leadership Pipeline Leadership After Action Review Pharmaceuticals 11

Harvard Business Review

OCTOBER 26, 2017

“He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. As with many clusters, a university sits at its center: founded in AD 1088, the Studium of Bologna was the major educational innovation of Europe’s second millennium.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

JUNE 16, 2011

So it is with most breakthrough innovations and banner financial years. Investors grapple daily in an effort to figure out how to value companies whose accounting assets — things like land, capital, products, and licenses — don't adequately express their true market value. If ego and time allow, the list can be quite long.

Intangible Assets 15

Intangible Assets Analysis Pharmaceuticals Innovation 15

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. For both public and private insurers, a long-term view should be feasible.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

SEPTEMBER 19, 2013

Previously untapped markets drive financial returns. New problem-solving innovators and investors power this solution economy. They range from Ashoka , which deploys 3,000 citizen changemakers in 70 countries, to the global pharmaceutical giants that annually give away billions of dollars in medicine to low-income citizens.

Pharmaceuticals 10

Pharmaceuticals Marketing Politics Bottom-up 10

Harvard Business Review

JUNE 14, 2017

And ease of access means ease of market entry: Emerging data providers can get on their feet quickly and create new sources of competition. How the most innovative providers are creating value. But as more data and more data providers flood the market, a competitive position based solely on data becomes impossible to defend.

Health Care 8

Health Care Levitt Competitive Advantage Pharmaceuticals 8

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

MAY 8, 2013

Over the past 20 years, no group has endured greater pain and humiliation within organizations than mid-level managers (MLMs — managers from two levels below the CEO down to the line managers). Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 8

Middle Management Management Automotive Pharmaceuticals 8

Harvard Business Review

DECEMBER 14, 2017

Is free-market magic finally bringing Amazon-style convenience, quality, and efficiency to health care? Some of the nation’s most innovative, high-performing non-profit health care organizations use this formula. Could this be it? Are old-guard institutions, like hospitals and nursing homes, on the verge of extinction?

Health Care 8

Health Care System Insurance Pharmaceuticals 8

Harvard Business Review

JUNE 16, 2016

The truth is that some of the problems we face today are simply too big and complex to be solved by any one organization. To understand the nature of the problem, let’s look at how penicillin was brought to market. Innovating the Innovation Process. The Valley of Death.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity.

Globalization 8

Globalization Supply Chain Pharmaceuticals McKinsey 8

Harvard Business Review

SEPTEMBER 5, 2016

The concept is fairly straightforward: The parties define the result up front, agree on a baseline, work out how confident the organization is in delivering the result, and then specify the expectation and payment in the contract. There is enough time to develop innovative solutions to achieve the results. Samuel Castro.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JANUARY 8, 2013

Breaking down functional silos is key to everything from encouraging communication to building valuable connections to sparking innovation. arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). "The Among the first 100 participants: BIPI's CEO, who was matched with a young member of one of the brand marketing teams. "A

Company 8

Company Pharmaceuticals Health Care Participative 8

Harvard Business Review

JANUARY 12, 2017

Organizations striving to find new ways to attack cancer have much to learn from direct-to-consumer (DTC) companies. Answering these questions will allow organizations involved in cancer research to meet patients where they are, just as DTC companies do. What can the field of precision oncology learn from this DTC approach? If so, how?

Company 8

Company Health Care Storytelling Pharmaceuticals 8

Harvard Business Review

FEBRUARY 2, 2015

Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

MAY 17, 2012

According to the World Health Organization, 75% of these deaths and ailments could be averted by simply keeping these premature babies warm. Enter jugaad innovation — a cost-effective approach for creating affordable products and services using limited resources. For us, innovation is a dynamic process that never ends.''.

Incubator 11

Incubator Business Model Entrepreneur Cost 11

Harvard Business Review

JANUARY 15, 2013

By inextricably linking the two, we confine the practice of real, turbo-charged capitalism to business, and we dangerously limit the capacity of non-business organizations to innovate, fund, and bring to scale the kind of breakthrough ideas that will begin to solve the huge social problems we face today. How do you monetize that?

Learning Curve 8

Learning Curve Advertising GDP Pharmaceuticals 8

Harvard Business Review

DECEMBER 18, 2014

This coalition has been able to consolidate the purchase of approximately $2 billion in medical devices, supplies, and pharmaceuticals each year, consistently saving 15% to 20% on contracted items year over year. It’s encouraging to see the creative collaboration hospitals are undertaking to reduce costs and improve outcomes.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

FEBRUARY 4, 2013

Just under 1,000 companies account for half of the world's market capitalization, Eccles notes. Our research with members of the global C-suite, and with leading sustainability and innovation experts, has identified seven vectors of breakthrough change. Perhaps surprisingly, two leading examples come from pharmaceutical companies.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

OCTOBER 24, 2017

These have forced AirBnB, Tesla, and Uber to make costly concessions to their operating practices or to exit certain markets altogether. Organized demonstrations of support by stakeholder groups can send a powerful signal to policymakers. Partner organizations. How can new firms overcome the regulations that protect incumbents?

Licensing 9

Licensing Proposal Retail Long-term 9

Harvard Business Review

DECEMBER 5, 2016

Library leaders knew that given the immense changes brought on by digital innovations, as well as shifts in the communities that the Library served, it would need to evolve. Innovation communities had been used by Best Buy to grow its portion of the women’s consumer electronics market by $4.4b How to get them engaged?

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

DECEMBER 23, 2016

” Members from each partner organization rate the alliance in areas related to strategic fit, operational fit, and cultural fit. These design differences have significant resource implications for both organizations. Heat degrades the substrate of innovation, while light catalyzes it.” Here’s an example.

Productivity 8

Productivity Products Survey Strategic Fit 8

Harvard Business Review

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. Older people need more medicine. Read More from the Government of Japan.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Content 8

Harvard Business Review

APRIL 24, 2017

In addition to homing in on targeted research and development efforts, governments have a unique obligation to work with the international community, such as the World Health Organization, to ensure a common response framework is in place, particularly in fragile states, whose health systems are underdeveloped. Science/technology community.

Project 8

Project Disaggregation Globalization Comparison 8

Harvard Business Review

SEPTEMBER 26, 2011

In the past 25 years, CEOs of many major corporations have relied on a flawed set of beliefs to lead their organizations. The stock market is short-term-oriented. The market favorably receives projects with long-term payoffs, particularly those in research and development. It is not for the profits. The profits follow." (By

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

SEPTEMBER 15, 2014

Now more than ever , businesses are reaching beyond the boundaries of their organizations, tapping experts, customers, and, more broadly, “the crowd” to build new products, services, and other solutions. Consider Ashoka , which provides start-up funding and support for social innovators worldwide.

Gilbert 8

Gilbert Participative Cooper Network Economy 8

Harvard Business Review

APRIL 13, 2015

Warren Buffett has earned his nickname because he’s proven time and again that he has an eye for predicting how markets will change and which companies will succeed in the aftermath. When markets or technologies change, it often requires entire segments of the value network to be reimagined. What’s changed?

Software 8

Software Trends Mass Marketing Marketing 8